Search Result "emesis"
The Role of Endocannabinoids and Arachidonic Acid Metabolites in Emesis
Ebook: Endocannabinoids: Molecular, Pharmacological, Behavioral and Clinical Features
Volume: 1 Year: 2013
Author(s): Nissar A. Darmani,Seetha Chebolu
Doi: 10.2174/9781608050284113010007
The Development of Future Research Strategies from Reviewing Antiemetic Trials for Chemotherapy Induced Emesis
Journal: Reviews on Recent Clinical Trials
Volume: 1 Issue: 1 Year: 2006 Page: 61-66
Author(s): Ian N. Olver
Mucoadhesive Buccal Patch Role in Emesis: Tweaked up by the Pivotal Permeation Enhancer: Sodium Lauryl Sulphate
Journal: Drug Delivery Letters
Volume: 10 Issue: 2 Year: 2020 Page: 96-103
Author(s): Kumar Nishchaya,Swatantra K.S. Kushwaha,Namra Aziz,Himanshu Bansode,Jagriti Tiwari,Abhitendra Kumar
Cannabinoid Receptor Activation and the Endocannabinoid System in the Gastrointestinal Tract
Journal: Current Neuropharmacology
Volume: 2 Issue: 1 Year: 2004 Page: 91-102
Author(s): A. A. Coutts
Medicinal Chemistry of Selective Neurokinin-1 Antagonists
Journal: Current Topics in Medicinal Chemistry
Volume: 3 Issue: 1 Year: 2003 Page: 1423-1435
Author(s): John M. Humphrey
Tachykinin Receptors Antagonists: From Research to Clinic
Journal: Current Drug Targets
Volume: 7 Issue: 8 Year: 2006 Page: 975-992
Author(s): Laura Quartara, Maria Altamura
Development and Potential Utility of Dual and Triple NK Receptor Antagonists
Journal: Current Topics in Medicinal Chemistry
Volume: 3 Issue: 1 Year: 2003 Page: 1410-1422
Author(s): Charles A. Rizzo, John C. Anthes, Michel R. Corboz, Richard W. Chapman, Neng-Yang Shih, Greg A. Reichard, Kwokei J. Ng, John A. Hey
Naldemedine: Peripherally Acting Opioid Receptor Antagonist for Treating Opioid-induced Adverse Effects
Journal: Current Topics in Medicinal Chemistry
Volume: 20 Issue: 31 Year: 2020 Page: 2830-2842
Author(s): Masanao Inagaki,Toshiyuki Kanemasa,Takaaki Yokota
Clinical Pharmacology of Serotonin Receptor Type 3 (5-HT3) Antagonists
Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 1 Issue: 2 Year: 2001 Page: 171-199
Author(s): Zafar H. israili
Cyclic AMP-Specific Phosphodiesterase-4 as a Target for the Development of Antidepressant Drugs
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 1 Year: 2009 Page: 1688-1698
Author(s): Han-Ting Zhang